Combined fracture and mortality risk evaluation for stratifying treatment in hip fracture patients: A feasibility study

dc.authorid0000-0001-5869-6571
dc.authorid0000-0002-5204-1029
dc.authorid0000-0002-0783-5591
dc.authorid0000-0002-9690-8907
dc.authorid0000-0001-8767-892X
dc.authorid0000-0002-8625-8648
dc.authorid0000-0002-9759-3062
dc.authorid0000-0003-1009-5042
dc.contributor.authorSezgin, Erdem Aras
dc.contributor.authorMarkeviçiute, Vetra
dc.contributor.authorŠirka, Aurimas
dc.contributor.authorTarasevic?ius, Šar?nas
dc.contributor.authorRaina, Deepak Bushan
dc.contributor.authorIsaksson, Hanna
dc.contributor.authorTägil, Magnus
dc.contributor.authorLidgren, Lars
dc.date.accessioned2021-02-05T10:37:32Z
dc.date.available2021-02-05T10:37:32Z
dc.date.issued2020
dc.departmentTıp Fakültesi
dc.descriptionSezgin, Erdem Aras ( Aksaray, Yazar )
dc.description.abstractObjectives: This study aims to test the feasibility of the Fracture and Mortality Risk Evaluation (FAME) Index. Patients and methods: Two academic centers in Lithuania and Turkey participated in this retrospective study conducted between November 2018 and July 2019. A total of 100 consecutive patients (22 males, 78 females; mean age 78.9 years; range, 45 to 100 years) with low energy proximal femur fractures admitted for surgery were included in the study. Fracture Risk Assessment tool (FRAX) and the Sernbo scores were calculated and patients were classified into one of the nine subcategories of the FAME Index. Results: Demographics and FAME Index classifications were similar between centers. Patients with high risk of fracture and low risk of mortality accounted for 18% of all patients, which is the FAME Index subcategory to theoretically benefit from cancellous bone augmentation during internal fixation of a fragility hip fracture the most. Conclusion: The FAME Index was successfully applied in clinical emergency setting utilizing a simple form, and demonstrated promising potential in stratification of hip fractures most suitable for screw and device augmentation. Larger studies with at least one-year of follow-up are warranted to verify the validity of FAME Index.
dc.identifier.doi10.5606/EHC.2020.73458
dc.identifier.endpage168en_US
dc.identifier.issn2687-4784
dc.identifier.issue2en_US
dc.identifier.pmid32315279
dc.identifier.scopusqualityQ2
dc.identifier.startpage163en_US
dc.identifier.urihttps:/dx.doi.org/10.5606/EHC.2020.73458
dc.identifier.urihttps://hdl.handle.net/20.500.12451/7735
dc.identifier.volume31en_US
dc.identifier.wosWOS:000545984600002
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherTurkish Joint Diseases Foundation
dc.relation.ispartofJoint Diseases and Related Surgery
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHip Fracture
dc.subjectIndex
dc.subjectOsteoporosis
dc.subjectRisk Factors
dc.subjectStratification
dc.titleCombined fracture and mortality risk evaluation for stratifying treatment in hip fracture patients: A feasibility study
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
sezgin-erdem aras-2020.pdf
Boyut:
394.78 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: